Free Trial

Rep. Lisa C. McClain Sells Revvity Inc. (NYSE:RVTY) Stock

Revvity logo with Medical background

Key Points

  • Representative Lisa C. McClain sold shares of Revvity Inc. (NYSE:RVTY) valued between $1,001 and $15,000 on July 22nd, as disclosed in a filing on August 13th.
  • Revvity's stock is currently down by 1.6% and is trading at $89.48, with a twelve-month low of $85.12 and a high of $129.50.
  • The company declared a quarterly dividend of $0.07 per share, which will be paid on November 7th, representing a 0.3% yield.
  • Want stock alerts on Revvity? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Representative Lisa C. McClain (R-Michigan) recently sold shares of Revvity Inc. NYSE: RVTY. In a filing disclosed on August 13th, the Representative disclosed that they had sold between $1,001 and $15,000 in Revvity stock on July 22nd. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

  • Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
  • Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
  • Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
  • Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
  • Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
  • Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
  • Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
  • Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
  • Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
  • Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.

Revvity Stock Down 1.2%

Shares of RVTY traded down $1.06 during mid-day trading on Monday, hitting $89.72. 976,599 shares of the company's stock were exchanged, compared to its average volume of 1,602,582. The firm has a fifty day moving average of $94.87 and a two-hundred day moving average of $99.60. Revvity Inc. has a twelve month low of $85.12 and a twelve month high of $129.50. The stock has a market cap of $10.41 billion, a price-to-earnings ratio of 18.56, a P/E/G ratio of 2.44 and a beta of 0.91. The company has a quick ratio of 2.75, a current ratio of 3.33 and a debt-to-equity ratio of 0.43.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings results on Monday, July 28th. The company reported $1.18 EPS for the quarter, topping the consensus estimate of $1.14 by $0.04. Revvity had a net margin of 10.19% and a return on equity of 7.66%. The company had revenue of $720.28 million for the quarter, compared to analyst estimates of $711.26 million. During the same quarter in the prior year, the business posted $1.22 EPS. Revvity's quarterly revenue was up 4.1% on a year-over-year basis. On average, sell-side analysts forecast that Revvity Inc. will post 4.94 earnings per share for the current year.

Revvity Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 7th. Stockholders of record on Friday, October 17th will be paid a dividend of $0.07 per share. The ex-dividend date is Friday, October 17th. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. Revvity's dividend payout ratio is 11.86%.

Analyst Ratings Changes

Several brokerages have recently commented on RVTY. UBS Group upgraded shares of Revvity from a "neutral" rating to a "buy" rating and dropped their price target for the stock from $145.00 to $115.00 in a research note on Thursday, May 1st. Bank of America lowered their target price on shares of Revvity from $116.00 to $110.00 and set a "buy" rating on the stock in a research note on Thursday, June 26th. Wall Street Zen lowered shares of Revvity from a "buy" rating to a "hold" rating in a research note on Sunday, August 3rd. Raymond James Financial reiterated an "outperform" rating and issued a $115.00 target price (down from $120.00) on shares of Revvity in a research note on Tuesday, July 29th. Finally, JPMorgan Chase & Co. lowered their target price on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 29th. Five equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $120.07.

Read Our Latest Stock Analysis on Revvity

Institutional Trading of Revvity

A number of hedge funds have recently bought and sold shares of the stock. T. Rowe Price Investment Management Inc. boosted its holdings in Revvity by 8.5% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 22,515,711 shares of the company's stock valued at $2,382,163,000 after purchasing an additional 1,754,403 shares during the period. Vanguard Group Inc. boosted its holdings in Revvity by 0.6% in the 1st quarter. Vanguard Group Inc. now owns 14,382,849 shares of the company's stock valued at $1,521,705,000 after purchasing an additional 92,638 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in shares of Revvity by 25.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 9,563,911 shares of the company's stock worth $1,011,863,000 after acquiring an additional 1,932,314 shares during the period. EdgePoint Investment Group Inc. lifted its holdings in shares of Revvity by 26.7% during the 2nd quarter. EdgePoint Investment Group Inc. now owns 6,789,660 shares of the company's stock worth $656,696,000 after acquiring an additional 1,428,813 shares during the period. Finally, Janus Henderson Group PLC lifted its holdings in shares of Revvity by 0.4% during the 4th quarter. Janus Henderson Group PLC now owns 6,358,952 shares of the company's stock worth $709,725,000 after acquiring an additional 23,650 shares during the period. 86.65% of the stock is owned by institutional investors.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Revvity

(Get Free Report)

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

See Also

Should You Invest $1,000 in Revvity Right Now?

Before you consider Revvity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.

While Revvity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines